Tumour fatty acid metabolism in the context of therapy resistance and obesity

AJ Hoy, SR Nagarajan, LM Butler - Nature Reviews Cancer, 2021 - nature.com
Fatty acid metabolism is known to support tumorigenesis and disease progression as well
as treatment resistance through enhanced lipid synthesis, storage and catabolism. More …

[HTML][HTML] Mechanisms of metabolic reprogramming in cancer cells supporting enhanced growth and proliferation

C Schiliro, BL Firestein - Cells, 2021 - mdpi.com
Cancer cells alter metabolic processes to sustain their characteristic uncontrolled growth
and proliferation. These metabolic alterations include (1) a shift from oxidative …

[HTML][HTML] Lipids and cancer: Emerging roles in pathogenesis, diagnosis and therapeutic intervention

LM Butler, Y Perone, J Dehairs, LE Lupien… - Advanced drug delivery …, 2020 - Elsevier
With the advent of effective tools to study lipids, including mass spectrometry-based
lipidomics, lipids are emerging as central players in cancer biology. Lipids function as …

[HTML][HTML] Prognosis and dissection of immunosuppressive microenvironment in breast cancer based on fatty acid metabolism-related signature

Y Tang, W Tian, J Xie, Y Zou, Z Wang, N Li… - Frontiers in …, 2022 - frontiersin.org
Fatty acid metabolism has been deciphered to augment tumorigenesis and disease
progression in addition to therapy resistance via strengthened lipid synthesis, storage, and …

[HTML][HTML] Mitochondria in cancer

D Grasso, LX Zampieri, T Capelôa, JA Van de Velde… - Cell stress, 2020 - ncbi.nlm.nih.gov
The rediscovery and reinterpretation of the Warburg effect in the year 2000 occulted for
almost a decade the key functions exerted by mitochondria in cancer cells. Until recent …

[HTML][HTML] Oncogenic pathways and the electron transport chain: a dangeROS liaison

V Raimondi, F Ciccarese, V Ciminale - British journal of cancer, 2020 - nature.com
Driver mutations in oncogenic pathways, rewiring of cellular metabolism and altered ROS
homoeostasis are intimately connected hallmarks of cancer. Electrons derived from different …

[HTML][HTML] Mitochondrial CPT1A: Insights into structure, function, and basis for drug development

K Liang - Frontiers in pharmacology, 2023 - frontiersin.org
Carnitine Palmitoyl-Transferase1A (CPT1A) is the rate-limiting enzyme in the fatty acid β-
oxidation, and its deficiency or abnormal regulation can result in diseases like metabolic …

[HTML][HTML] Reprogramming of lipid metabolism in lung cancer: An overview with focus on EGFR-Mutated non-small cell lung cancer

K Eltayeb, S La Monica, M Tiseo, R Alfieri, C Fumarola - Cells, 2022 - mdpi.com
Lung cancer is the leading cause of cancer deaths worldwide. Most of lung cancer cases are
classified as non-small cell lung cancers (NSCLC). EGFR has become an important …

[HTML][HTML] Lipid metabolism and endocrine resistance in prostate cancer, and new opportunities for therapy

GE Stoykova, IR Schlaepfer - International journal of molecular sciences, 2019 - mdpi.com
Prostate cancer (PCa) is the most common cancer in men, and more than 10% of men will
be diagnosed with PCa during their lifetime. Patients that are not cured with surgery or …

Too complex to fail? Targeting fatty acid metabolism for cancer therapy

R Munir, J Lisec, JV Swinnen, N Zaidi - Progress in lipid research, 2022 - Elsevier
Given the central role of fatty acids in cancer pathophysiology, the exploitation of fatty acid
metabolism as a potential antineoplastic therapy has gained much attention. Several natural …